Back
Fulcrum Therapeutics Vs. Avidity Biosciences Industry Stock Comparison
Buy
61
FULC
Fulcrum Therapeutics
Last Price:
$7.65
Seasonality Move:
24.14%
Sell
40
RNA
Avidity Biosciences
Last Price:
$33.80
Seasonality Move:
-9.57%
Buy
61
Fulcrum Therapeutics (FULC)
is a Buy
Is Fulcrum Therapeutics a Buy, Sell or Hold?
-
The current Fulcrum Therapeutics [FULC] share price is $7.65. The Score for FULC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
FULC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $33.76. The Score for RNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $7.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $33.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.18 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | -363618 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.76 - 7.76) | Buy |
Bollinger Bands (100): | (3.2 - 7) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.24 | Buy |
Relative Strength Index (14 RSI): | 61.58 | Buy |
Chaikin Money Flow: | -1781609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.8 - 32.26) | Buy |
Bollinger Bands (100): | (27.85 - 32.67) | Buy |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.87 | Sell |
20-day SMA: | 7.42 | Buy |
50-day SMA: | 6.87 | Buy |
200-day SMA: | 4.46 | Buy |
8-day EMA: | 7.02 | Buy |
20-day EMA: | 4.66 | Buy |
50-day EMA: | 2.38 | Buy |
200-day EMA: | 0.68 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.6 | Buy |
20-day SMA: | 30.57 | Buy |
50-day SMA: | 30.85 | Buy |
200-day SMA: | 34.32 | Sell |
8-day EMA: | 29.54 | Buy |
20-day EMA: | 19.33 | Buy |
50-day EMA: | 9.78 | Buy |
200-day EMA: | 2.78 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.37 per share, a decrease this year of $1.00 per share, and a decrease next year of $0.06 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.45 per share.
Fulcrum Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |